{"id":"W2742165495","doi":"","title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: Results of a randomised placebo-controlled trial (ABILITY-1)","year":2013,"lang":"en","type":"article","venue":"QUT ePrints (Queensland University of Technology)","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Procter and Gamble; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories","keywords":"Adalimumab; Medicine; BASDAI; Ankylosing spondylitis; Placebo; Spondylitis; Internal medicine; Clinical endpoint; Visual analogue scale; Physical therapy; Randomized controlled trial; Arthritis; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003223468,0.00175729,0.003898796,0.00054055,0.0005251937,0.001624277,0.001270037,0.002653331,0.008335913],"category_scores_gemma":[0.003386541,0.0008007545,0.002330824,0.0004562679,0.001379747,0.001349963,0.0004993389,0.002592668,0.001237317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007012115,"about_ca_system_score_gemma":0.0008949447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004886744,"about_ca_topic_score_gemma":0.0009465149,"domain_scores_codex":[0.9982346,0.001078341,0.0001677852,0.0002385793,0.0001171151,0.0001634964],"domain_scores_gemma":[0.9980234,0.0006723448,0.000553085,0.0001613944,0.0001341681,0.0004556179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9842606,0.004227204,0.0003851423,0.0006297951,0.0005146499,0.00002297585,0.00003127414,0.00006861888,0.001262745,0.00002380657,0.0002329665,0.008340254],"study_design_scores_gemma":[0.9442863,0.05349906,0.001435948,0.00003123945,0.0002374395,0.00002207232,0.00001090787,0.00007959728,0.0001500102,0.00002549078,0.0002139354,0.000007974617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819925,0.01182648,0.0004022932,0.0006700084,0.0006717826,0.002150705,0.0007837219,0.0001151346,0.001387478],"genre_scores_gemma":[0.9851567,0.004322974,0.001172237,0.001052525,0.001240582,0.003677494,0.001051112,0.00002677758,0.002299561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008335913,"threshold_uncertainty_score":0.02788645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003545603562280225,"score_gpt":0.1861699903924091,"score_spread":0.1826243868301288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}